Mako Nagayoshi

Lecturer

Nagoya University Graduate School of Medicine
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (12)

Year:

2026

Year:

2026

Background Although utility of composite trait‐specific polygenic risk score (multi‐trait PRS) has been examined among European ancestries, few studies investigated among East Asians and incorporated modifiable risk factors. We examined the associations of multi‐trait PRS for cardiometabolic factors with cardiovascular disease mortality by integrating nongenetic determinants. Methods A total of 14 086 Japanese participants (mean age, 55±9; 55.8% women) of the J‐MICC (Japan Multi‐Institutional Collaborative Cohort) study were analyzed in this study. We calculated 6 PRSs for cardiometabolic traits (systolic blood pressure, body mass index, triglycerides, low‐density lipoprotein cholesterol, estimated glomerular filtration rate, and hemoglobin A1c). Based on these PRSs, we developed multi‐trait PRS and considered as a primary exposure. Three nongenetic factors (smoking, alcohol drinking, and educational attainment) from the self‐reported questionnaire were also examined. Results During a median 12.1‐year follow‐up period, a total of 472 all‐cause and 79 cardiovascular disease mortality cases were documented. Compared with 0% to 90% of multi‐trait PRSs, an adjusted hazard ratio (HR) among the top 10% of multi‐trait PRSs was 1.32 (95% CI, 1.00–1.73) for all‐cause death and 2.63 (95% CI, 1.48–4.67) for cardiovascular disease death. Incorporation of educational attainment with multi‐trait PRSs showed null associations in those who went beyond high school (HR, 2.07 [95% CI, 0.44–9.66]) even in the top 10% of multi‐trait PRS. Conclusions Our analysis combining both genetic and nongenetic determinants highlighted that lifestyle factors and educational attainment can slightly reduce an individual's composite genetic risk for cardiovascular disease death.

Year:

2025

Background Staying active in daily life is believed to help maintain individuals' oral motor function and prevent oral frailty, a potential risk factor for general health. However, there is limited epidemiological evidence of this association. This study focused on vocalising frequency as an indicator of activeness in daily life. Methods We conducted a home‐visit survey targeting residents aged ≥ 65 years in a rural community in the Goto Islands, Japan. Among 563 participants, those with missing data for the main outcome or vocalising ( n = 84) were excluded. Tongue pressure was measured thrice; we used maximum tongue pressure as a marker of tongue motor function. Frequency of conversation, laughter and other vocalising opportunities (e.g., singing or Buddhist chanting) was measured. The multivariate‐adjusted regression models were used to calculate parameter estimates (B) for tongue pressure according to the frequency of vocalisation. Results Among the 479 participants, the proportion of individuals who answered ‘every day’ was 77% for conversation, 48% for laughter and 47% for other vocalising opportunities. Participants engaging every day in other vocalising opportunities recorded higher maximum tongue pressure ( B = 2.26; p = 0.03) than those who did not at all. Sex did not affect this association ( p interaction = 0.72). Conversation and laughter every day overlapped with the everyday category of other vocalising opportunities, but they were not associated with tongue pressure. Conclusion Engaging every day in vocalising opportunities other than conversation or laughter was independently associated with a higher maximum tongue pressure in older adults than those who vocalised less often.

Year:

2025

Year:

2025

Flowcharts of the selection of study participants. A, Study participants for analyses of examination-based metabolic phenotypes. B, Study participants for analyses of questionnaire-based metabolic phenotypes.

Year:

2025

The present study investigated the relationship between metabolic phenotypes and the risk of cancer in a Japanese population using the criteria of metabolic phenotypes based on an examination and those based on questionnaires. We used data from 25,357 subjects for examination-based analyses and those from 53,042 subjects for questionnaire-based analyses in the Japan Multi-institutional Collaborative Cohort study. Metabolic phenotypes were defined by classifying subjects according to their body mass index (BMI; obesity: BMI ≥25 kg/m2; normal weight: BMI <25 kg/m2) and the number of metabolic abnormalities. Metabolic abnormalities were defined according to metabolic syndrome components of the Joint Interim Statement criteria for examination-based analyses and self-reported histories of diabetes, dyslipidemia, and hypertension for questionnaire-based analyses. Cox proportional hazards regression analyses adjusted for potential confounders were performed for total and site-specific cancer incidence rates according to metabolic phenotypes. Metabolically unhealthy obesity (MUHO) was significantly associated with cancer incidence in both examination-based [HR (95% confidence interval), 1.17 (1.01–1.36)] and questionnaire-based analyses [HR (95% confidence interval), 1.15 (1.04–1.26)]. Regarding site-specific cancer in questionnaire-based analyses, metabolically healthy obesity and MUHO were associated with colorectum and liver cancers in all subjects and with breast cancer in female subjects. Subjects with a metabolically unhealthy normal weight had a higher risk of pancreatic cancer. Moreover, MUHO was associated with corpus uteri cancer in female subjects. This prospective cohort study suggests that metabolic phenotypes are important risk factors for total and some site-specific cancers in Japanese adults. Significance: The prospective cohort study in a large Japanese population suggested that metabolic phenotypes are important risk factors for total and some site-specific cancers in Japanese adults. Moreover, the risk of each site-specific cancer may differ according to metabolic phenotypes.

Year:

2024

Year:

2024

The present study investigated the relationship between metabolic phenotypes and the risk of cancer in a Japanese population using the criteria of metabolic phenotypes based on an examination and those based on questionnaires. We used data from 25,357 subjects for examination-based analyses and those from 53,042 subjects for questionnaire-based analyses in the Japan Multi-institutional Collaborative Cohort study. Metabolic phenotypes were defined by classifying subjects according to their body mass index (BMI; obesity: BMI ≥25 kg/m 2 ; normal weight: BMI 2 ) and the number of metabolic abnormalities. Metabolic abnormalities were defined according to metabolic syndrome components of the Joint Interim Statement criteria for examination-based analyses and self-reported histories of diabetes, dyslipidemia, and hypertension for questionnaire-based analyses. Cox proportional hazards regression analyses adjusted for potential confounders were performed for total and site-specific cancer incidence rates according to metabolic phenotypes. Metabolically unhealthy obesity (MUHO) was significantly associated with cancer incidence in both examination-based [HR (95% confidence interval), 1.17 (1.01–1.36)] and questionnaire-based analyses [HR (95% confidence interval), 1.15 (1.04–1.26)]. Regarding site-specific cancer in questionnaire-based analyses, metabolically healthy obesity and MUHO were associated with colorectum and liver cancers in all subjects and with breast cancer in female subjects. Subjects with a metabolically unhealthy normal weight had a higher risk of pancreatic cancer. Moreover, MUHO was associated with corpus uteri cancer in female subjects. This prospective cohort study suggests that metabolic phenotypes are important risk factors for total and some site-specific cancers in Japanese adults. Significance: The prospective cohort study in a large Japanese population suggested that metabolic phenotypes are important risk factors for total and some site-specific cancers in Japanese adults. Moreover, the risk of each site-specific cancer may differ according to metabolic phenotypes.

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

Teruhide Koyama

Kyoto Prefectural University of Medicine

JAPAN
View details

TAKUMA FURUKAWA

Assistant Professor

Saga University

JAPAN
View details

Megumi Hara

Associate professor

Saga Daigaku

JAPAN
View details

Ryosuke Fujii

Senior Assistant Professor

Fujita Health University

JAPAN
View details

Chisato Shimanoe

Director/ Professor

Saga University

JAPAN
View details

Masashi Ishizu-Jo

Assistant Professor

Tokushima University

JAPAN
View details

Kazuhiko Watanabe

Assistant professor

University of Occupational and Environmental Health Japan

JAPAN
View details

Koji Suzuki

Professor

Fujita Health University

JAPAN
View details

Hiroaki Ikezaki

Associate Professor

Kyushu University Graduate School of Medical Sciences

JAPAN
View details

Isao Oze

Unit Leader

Aichi Cancer Center

JAPAN
View details

Keitaro Tanaka

Saga University

JAPAN
View details

Yuriko N Koyanagi

Aichi Cancer Center

JAPAN
View details

Shuntaro Sato

Nagasaki University

JAPAN
View details

Takeshi Watanabe

Assistant Professor

Tokushima University

JAPAN
View details

Naoyuki Takashima

Professor

Kyoto Prefectural University of Medicine

JAPAN
View details

Keitaro Matsuo

Chief

Nagoya University

JAPAN
View details

Sadao Suzuki

Professor

Nagoya Daigaku

JAPAN
View details

Nobuaki Michihata

The Univeristy of Tokyo

JAPAN
View details

Hidemi Ito

Division Chief

Aichi Cancer Center

JAPAN
View details